- Home
- MEGL vs CELZ Comparison
MEGL vs CELZ Comparison
Compare MEGL & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MEGL | CELZ |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 10.4M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | MEGL | CELZ |
|---|---|---|
| Price | $1.27 | $2.28 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.1K | ★ 99.9K |
| Earning Date | 12-11-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,296,394.00 | $6,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.02 | $1.69 |
| 52 Week High | $5.52 | $6.90 |
Technical Indicators
Market Signals| Indicator | MEGL | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 45.32 | 32.79 |
| Support Level | $1.23 | $2.10 |
| Resistance Level | $1.30 | $2.41 |
| Average True Range (ATR) | 0.10 | 0.19 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 16.09 | 8.97 |
Price Performance
Historical ComparisonAbout MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.